
Rsan Pharmaceuticals Private Limited
Manufactures pharmaceuticals with registered office in Solan, Himachal Pradesh.
Manufactures pharmaceuticals with registered office in Solan, Himachal Pradesh.
Solan, Himachal Pradesh, India
+91-XXXXXXXXXX
U24233HP2015PTC000860
000860
Private Limited Indian Non-Government Company
02 Feb 2015
05 Nov 2020
31 Mar 2020
Unlisted
Roc Himachal Pradesh
Name | Designation | Appointment Date | Status |
---|---|---|---|
Nalini Garg ![]() | Director | 02-Feb-2015 | Current |
Sukh Singh ![]() | Director | 02-Feb-2015 | Current |
Rsan Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
In 2017, Rsan Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Nalini Garg is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Rsan Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Rsan Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rsan Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Rsan Pharmaceuticals Private Limited last Annual general meeting of members was held on 05 Nov 2020 as per latest MCA records.
Rsan Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Himachal Pradesh.
Nalini Garg was appointed as a Director was appointed as a Director on 02 Feb 2015 & has been associated with this company since 10 years 4 months .
Sukh Vir Singh was appointed as a Director was appointed as a Director on 02 Feb 2015 & has been associated with this company since 10 years 4 months .
Rsan Pharmaceuticals Private Limited was registered on 02 Feb 2015 with Roc Himachal Pradesh & aged 10 years 4 months as per MCA records.
Rsan Pharmaceuticals Private Limited was incorporated on 02 Feb 2015.
The authorized share capital of Rsan Pharmaceuticals Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Rsan Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Rsan Pharmaceuticals Private Limited is House Anand Niwas Bypass Road India, Kumarhatti, Himachal Pradesh, 173212.
The corporate identification number (CIN) of Rsan Pharmaceuticals Private Limited is U24233HP2015PTC000860 and the company number is 000860 as per Ministry of Corporate Affairs (MCA).
The most recent Balance Sheet for Rsan Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2020.
Search company & director profiles for free and gain access to critical business data.